✦ LIBER ✦

RELATION BETWEEN IMMUNOCYTOCHEMICAL ESTIMATION OF OESTROGEN RECEPTOR IN ELDERLY PATIENTS WITH PRIMARY BREAST CANCER AND RESPONSE TO TAMOXIFEN

✍ Scribed by Gaskell, D.J; Sangsterl, K; Hawkins, R.A; Chetty, U; Forrest, A.P.M

Book ID: 123555135
Publisher: The Lancet
Year: 1989
Tongue: English
Weight: 460 KB
Volume: 333
Category: Article
ISSN: 0140-6736
DOI: 10.1016/S0140-6736(89)92445-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

BENEFICIAL EFFECT OF ADJUVANT TAMOXIFEN

BENEFICIAL EFFECT OF ADJUVANT TAMOXIFEN THERAPY IN PRIMARY BREAST CANCER PATIENTS WITH HIGH OESTROGEN RECEPTOR VALUES

✍ ROSE, C 📂 Article 📅 1985 🏛 The Lancet 🌐 English ⚖ 546 KB

Biological profile of oestrogen receptor

Biological profile of oestrogen receptor positive primary breast cancers in the elderly and response to primary endocrine therapy

✍ G. Okunade; A.R. Green; M. Ying; A. Agrawal; E.C. Paish; M. Aleskandrany; L. Win 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 337 KB

Tumour oestrogen receptor content allows

Tumour oestrogen receptor content allows selection of elderly patients with breast cancer for conservative tamoxifen treatment

✍ Mr S. C. Low; A. R. Dixon; J. Bell; I. O. Ellis; C. W. Elston; J. F. R. Robertso 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 290 KB 👁 1 views

Preoperative serum VEGF in primary breas

Preoperative serum VEGF in primary breast cancer patients — Its relation with oestrogen receptor status and cancer type

✍ K. Heer; H. Kumar; V. Speirs; P.J. Drew; N.J. Fox; J.P. Carleton; R.T.J. Monson; 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 147 KB

Expression of the HOXB13-to-IL 17BR-gene

Expression of the HOXB13-to-IL 17BR-gene ratio in oestrogen receptor positive primary breast carcinomas: Relation with tumour aggressiveness and response to tamoxifen

✍ M. Jansen; Sieuwerts; M. Look; K. Ritstier; M. Meijer-van Gelder; I. van Stavere 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 132 KB

Prediction of response to endocrine ther

Prediction of response to endocrine therapy in breast cancer using immunocytochemical assays for pS2, oestrogen receptor and progesterone receptor

✍ Y. A. Luqmani; D. Ricketts; G. Ryall; L. Turnbull; M. Law; R. C. Coombes 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 French ⚖ 802 KB

Histological sections obtained from 70 patients with breast cancer, all of whom had received endocrine therapy for metastatic or locally advanced disease, were assessed for specific immunocytochemical staining of oestrogen receptor and the oestrogen-induced protein pS2. There was also sufficient mat